BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24708261)

  • 1. Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.
    Kanazawa T; Morisaki K; Suzuki S; Takashima Y
    Mol Pharm; 2014 May; 11(5):1471-8. PubMed ID: 24708261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
    Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
    Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
    Kanazawa T; Taki H; Tanaka K; Takashima Y; Okada H
    Pharm Res; 2011 Sep; 28(9):2130-9. PubMed ID: 21499835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.
    Taki H; Kanazawa T; Akiyama F; Takashima Y; Okada H
    Pharmaceuticals (Basel); 2012 Oct; 5(10):1092-102. PubMed ID: 24281259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.
    Kanazawa T; Taki H; Okada H
    Eur J Pharm Biopharm; 2020 Jul; 152():85-94. PubMed ID: 32387702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
    Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
    Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis.
    Ibaraki H; Hatakeyama N; Arima N; Takeda A; Seta Y; Kanazawa T
    Eur J Pharm Biopharm; 2022 Jan; 170():170-178. PubMed ID: 34963657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
    Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
    Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery.
    Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H
    Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
    Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
    Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
    Kanazawa T
    Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effects in a Transient Middle Cerebral Artery Occlusion Rat Model by Nose-To-Brain Delivery of Anti-TNF-Alpha siRNA with Cell-Penetrating Peptide-Modified Polymer Micelles.
    Kanazawa T; Kurano T; Ibaraki H; Takashima Y; Suzuki T; Seta Y
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31540164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin.
    Song J; Zhang Y; Zhang W; Chen J; Yang X; Ma P; Zhang B; Liu B; Ni J; Wang R
    Peptides; 2015 Jan; 63():143-9. PubMed ID: 25496911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
    Park EK; Kim SY; Lee SB; Lee YM
    J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy.
    Jiang C; Wang H; Zhang X; Sun Z; Wang F; Cheng J; Xie H; Yu B; Zhou L
    Int J Pharm; 2014 Nov; 475(1-2):60-8. PubMed ID: 25152167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel polymeric micelles as enzyme-sensitive nuclear-targeted dual-functional drug delivery vehicles for enhanced 9-nitro-20(S)-camptothecin delivery and antitumor efficacy.
    Sun Y; Liang Y; Hao N; Fu X; He B; Han S; Cao J; Ma Q; Xu W; Sun Y
    Nanoscale; 2020 Mar; 12(9):5380-5396. PubMed ID: 32022069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration.
    Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.